21st Century Oncology joins KKR's GenesisCare in $1.1 bln deal

The PE-backed Aussie cancer and cardiac care provider prevailed over two other parties in Jefferies-run sales process

13 December 2019•2 mins read
21st Century Oncology, GenesisCare, KKR,
LinkedInXEmail
LinkedInXEmail

Related articles